CPD (anticoagulant citrate phosphate dextrose- cpd solution

CPD by

Drug Labeling and Warnings

CPD by is a Prescription medication manufactured, distributed, or labeled by Fenwal, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Caution: Do not use unless solutions are clear.

  • 1. Identify Blood-Pack unit using appropriate donor identification system for autologous transfusion.
  • 2. Open package containing Y-Type Connector set. Close clamps.
  • 3. Remove protector from the inlet tubing of the Blood-Pack unit(s).
  • 4. Remove protector from the coupler on one lead of the set by slightly pushing on one side of the cap and then pulling the cap in a straight direction. Insert coupler into the inlet tubing of the Blood-Pack unit with a twisting motion until firmly seated.
  • 5. Repeat step 4 with second Blood-Pack unit and the remaining lead on the Y-Type Connector set if a second unit is to be collected.
  • 6. Prime the set with anticoagulant from one Blood-Pack unit by slowly opening clamp on one lead of the set to permit the solution to completely fill the set. Close clamp.
  • 7. Place the Blood-Pack unit(s) in an inverted position below the level of the blood withdrawal site.
  • 8. Attach lead with Luer connector to the arterial line, central venous pressure line, or peripheral venous line access.

    • Provision should be made to replace the volume of blood collected either prior to or simultaneously with the collection in a manner prescribed by the attending physician.

  • 9. To begin collection, open the clamp on the patient access line and the lead that was used to prime the Y-Type Connector set. Collect 450 mL ± 10% of blood in the first Blood-Pack unit. Mix blood and anticoagulant solution while filling. Close clamp on the lead of the Y-Type Connector set.

    • Note:

  • Use a scale or other appropriate means to ensure adequate collection of proper volume.
  • 10. If a second unit is to be collected, open the clamp on the patient access line and the lead that was used to prime the Y-Type Connector set. Collect 450 mL ± 10% of blood in the second Blood-Pack unit. Mix blood and anticoagulant solution while filling. Close clamp on the lead of the Y-Type Connector set.

    • Precaution:

  • Collection of the second unit should be initiated within approximately 4 minutes of collection of the first unit to avoid possible clot formation in the tubing.
  • 11. Close or clamp the access line to prevent blood loss or air getting into the system or patient. Disconnect the Luer connector from the access line.

    • Precaution:

  • Steps 12-15 should be performed within approximately 4 minutes after collection to avoid possible clot formation in the tubing.
  • 12. If donor samples are desired, collect donor samples following established procedures.
  • 13. Seal inlet tubing of the Blood-Pack unit(s).
  • 14. If the inlet tubing is not sealed directly above the collection container, then strip the blood from the remaining inlet tubing into the collection container. Mix and allow tubing to refill; repeat once. Seal tubing at X marks on the inlet tubing and leave segments attached to the collection container.
  • 15. Mix blood and anticoagulant solution, label and store in appropriate manner.

    • Caution: This Blood-Pack unit is for autologous transfusion only. Blood collected should be stored at conditions appropriate for an autologous collection. Store at 1-6°C and reinfuse within 24 hours of collection.

    FENWAL and Blood-Pack are registered trademarks of Fenwal, Inc.

    logoFenwal, Inc.
    Lake Zurich, IL 60047 USA

    Made in USA

    07-19-54-238    Iss. 11/2007

  • PACKAGE/LABEL DISPLAY PANEL

    Code 4R0499

    2 Units

    Fenwal™

    Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK™ Unit

    Single For Collection of 450 mL of Autologous Blood

    Rx only

    Each unit consists of a PL 146 Plastic primary container with 63 mL of CPD solution containing 1.66 g Sodium Citrate (dihydrate) USP, 1.61 g Dextrose (monohydrate) USP, 188 mg Citric Acid (anhydrous) USP and 140 mg Monobasic Sodium Phosphate (monohydrate) USP. pH may have been adjusted with sodium hydroxide.

    Sterile, non-pyrogenic fluid path.
    See direction insert.

    Store at Controlled Room Temperature (refer to direction insert).

  • Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture.
  • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth.
  • Units removed from the foil pouch must be used within 4 days (96 hours). Units out of the foil pouch for longer than 4 days must be discarded.

    • FENWAL and BLOOD-PACK are trademarks of Fenwal, Inc.

    logo Fenwal, Inc.
    Lake Zurich, IL 60047 USA
    Made in USA

    07-28-05-649 REV: A

    Anitcoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit label
  • INGREDIENTS AND APPEARANCE
    CPD 
    anticoagulant citrate phosphate dextrose (cpd) solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC: 0942-9206
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (Anhydrous Citric Acid - UNII:XF417D3PSL) Anhydrous Citric Acid1.66 g  in 63 mL
    DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK) DEXTROSE MONOHYDRATE1.61 g  in 63 mL
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (Anhydrous Citric Acid - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID188 mg  in 63 mL
    SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) (PHOSPHATE ION - UNII:NK08V8K8HR) SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE140 mg  in 63 mL
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC: 0942-9206-0163 mL in 1 BAG; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NDABN17040103/01/2007
    Labeler - Fenwal, Inc. (794519020)
    • © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.